Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tonix Pharma Stock’s Retail Chatter Explodes After FDA Nod For New Drug Application
Via Stocktwits
Exposures Product Safety
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) Lead Plaintiff Deadline is February 18, 2025
Via NewMediaWire
Exposures Product Safety
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) Lead Plaintiff Deadline is February 18, 2025
Via TheNewswire.com
Exposures Product Safety
Merck Discontinues Certain Cancer Candidate Trials After Futility Analysis
Via Benzinga
Exposures Product Safety
Tickers MRK
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Via Benzinga
Exposures Product Safety
Tickers BAYRY REGN
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
Via Benzinga
Exposures Product Safety
Tickers AZN JNJ
Salignostics Secures TGA Approval for Saliva-Based Home Pregnancy Test
Via News Direct
Exposures Product Safety
US Marijuana Research is Witnessing an Evolving Landscape
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Colorectal Surgery Leader Dr. I. Emre Gorgun Joins Actuated Medical's Medical Advisory Board
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
US Marijuana Research is Witnessing an Evolving Landscape
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis Product Safety
Tickers CURLF
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI BTAI HWAIF ICAD
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Treatment with FDA NDA Acceptance
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance
Via AB Newswire
Topics Economy
Exposures Interest Rates Product Safety
New Approaches to Psychedelic Clinical Trials Could Overcome Regulatory Hurdles
Via Investor Brand Network
Exposures Product Safety
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics
Via News Direct
Exposures Product Safety
Tickers MBOT
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Via Benzinga
Exposures Product Safety
Tickers CKPT
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
Via Benzinga
Exposures Product Safety
Tickers CRNX NBIX
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Neurocrine Wins FDA Approval For Genetic Disorder Drug
Via Investor's Business Daily
Exposures Product Safety
Tickers ABBV NBIX
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
Via Benzinga
Topics Government
Exposures Political Product Safety
Tickers GSK PFE SNY
Why Is Repare Therapeutics Stock Trading Lower On Friday?
Via Benzinga
Exposures Product Safety
Tickers RPTX
Clene Inc. (NASDAQ: CLNN) Receives FDA Guidance on Accelerated Approval Pathway for CNM-Au8(R) for ALS
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Bill Gates Recalls The Time Warren Buffett Slept Over And Ate Oreos For Breakfast – 'Poor Example For Young People' But It Works For Him
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Medico-Legal Expert Questions Sustainability of Low-Cost, Compounded GLP-1 Drugs for Weight Loss
Via Press Advantage
Topics Lawsuit
Exposures Financial Legal Product Safety
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
Via Newsfile
Topics Government Supply Chain
Exposures Political Product Safety Supply Chain
Tickers XXII
DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids
Via Benzinga
Exposures Product Safety
Tickers DBVT
BOQU Instrument – Pioneering Excellence in Water Quality Analysis
Via AB Newswire
Exposures Product Safety
Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options
Via Benzinga
Exposures Product Safety
Tickers CLRB
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.